Peptide record

TPDB93207

APO-Ang2 Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB93207
APO-Ang2
Blood-Brain Barrier Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia CPPsite3.0
modified_plain
Yes
A 19-aa modified multi-activity (Blood-Brain Barrier and Cell-penetrating Peptides) peptide sequence curated from B3Pred, BBPpredict, Peptipedia, and other sources, with an available 3D structural model.
N-terminal: Conjugated with ASA drug
Sequence
TFFYGGSRGKRNNFKTEEY
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
19 reviewed residue count
Linear Activity
Conjugated with ASA drug Activity
ThrPhePheTyrGlyGlySerArgGlyLysArgAsnAsnPheLysThrGluGluTyr Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

Blood-Brain Barrier

Target

CHO cell line

Assay & Model

2.5 microgram/ ml
cellular uptake assay
13 % cellular uptake
Lysosomal disorder

Source & Reference

NA
B3Pdb

Other

Transendocytosis
Evidence 2 Activity

Activity

Blood-Brain Barrier

Target

bEND cell line

Assay & Model

2.5 microgram/ ml
cellular uptake assay
22.9 % cellular uptake
Lysosomal disorder

Source & Reference

NA
B3Pdb

Other

Transendocytosis
Evidence 3 Activity

Activity

Blood-Brain Barrier

Target

PBCECs cell line

Assay & Model

0.02% cells were added
Basolateral screening assay
120% transfer
Lysosomal disorder

Source & Reference

NA
B3Pdb

Other

Basolateral